Biophotonic Platform - Esophageal Application

About Guided Therapeutics

Guided Therapeutics (GTHP) is a public, commercial-stage diagnostics company with a 30+ year mission to transform cancer screening through its non-invasive biophotonic platform. Its core achievement is the CE-marked LuViva system for cervical cancer detection, which provides immediate, point-of-care results and has demonstrated the potential for earlier detection than traditional methods in clinical studies. The company's strategy focuses on securing FDA approval, expanding international distribution via partners, and leveraging its platform technology into adjacent oncology diagnostics, such as esophageal cancer, to drive growth.

Therapeutic Areas